HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Lawyer Advises FDA-Enforced CIR Compliance, Not Drug/Food Regulatory Split

This article was originally published in The Rose Sheet

Executive Summary

Cosmetics are not more closely related to drugs than foods, nor should they be moved along with foods into a separate regulatory agency, says former FDA Chief Counsel Peter Barton Hutt

You may also be interested in...



Council “Going For Broke,” Seeks $4.5 Mil. For FDA’s Cosmetics Office In 2010

Having successfully lobbied for increased funding for FDA's cosmetics program, which received a $1 million bump in the last two annual spending packages, the Personal Care Products Council is asking Congress to boost the office's budget by $4.5 million - to a cool $10 million - in fiscal 2010

Industry Must Unite To Preserve Consumer Faith – New Council Chair Brestle

The personal-care industry needs to speak "with one voice" in order to strengthen consumer confidence in the safety of its products, Personal Care Products Council Chairman Dan Brestle urged at the trade association's annual meeting in Boca Raton, Fla

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Latest Headlines
See All
UsernamePublicRestriction

Register

RS016131

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel